Active Pharmaceutical Ingredient Watch
23 September 2002 00:00 [Source: ICB Americas]
CODEXIS Inc., a subsidiary of Maxygen Inc., received its first commercial payment and two separate milestone payments in its collaboration with Pfizer Inc. relating to improvements of the biosynthetic pathway in the production of a Pfizer drug. Codexis applied its MolecularBreeding directed molecular evolution technologies.ELI LILLY and Company received an approvable letter from the Food and Drug Administration for Cym-balta (duloxetine), a dual reuptake inhibitor that works through two key neurotransmitters involved in depression-serotonin and norepinephrine.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
Related Articles
- 15 Nov 12 12:00 Health Canada approves Eli Lilly Canada Inc's Cymbalta for knee pain
- 02 Dec 10 12:00 Impax Laboratories receives tentative FDA approval for generic Cymbalta delayed-release 20, 30 and 60 mg capsules
- 07 Dec 09 12:00 FDA approves Cymbalta for maintenance treatment of generalized anxiety disorder
- 24 Nov 08 00:00 Impax sued based on ANDA for generic Cymbalta
- 18 Sep 08 00:00 Pipeline and commercial insight: fibromyalgia - approvals legitimize condition and expose underserved patient population (Ref: DMHC2405)
- 23 Jun 08 00:00 FDA approves Cymbalta for the management of fibromyalgia
- 18 Jun 08 00:00 Patients taking Cymbalta reported reduced pain severity of osteoarthritis of the knee in new study
- 04 Jun 08 00:00 Lilly submits Cymbalta supplemental New Drug Application for chronic pain to US Food and Drug Administration
- 26 Mar 07 00:00 Cymbalta approved to treat GAD in US: Eli Lilly
- 24 Dec 05 00:02 New study suggests Cymbalta reduced depression symptoms at least as fast as a leading competitor.
Latest News
- 24 May 13 14:24 US durable goods orders rise 3.3% in April from March
- 24 May 13 14:03 West Africa PE, PP demand expected to slow
- 24 May 13 13:53 Europe petchem producers 'face hurdles sourcing US shale gas'
- 24 May 13 13:46 No big changes expected for Europe June ethylene, propylene
- 24 May 13 13:00 VIDEO: ICIS Europe Lunchtime Bulletin 24 May 2013